Labral hypertrophy correlates with borderline hip dysplasia and microinstability in femoroacetabular impingement: a matched case-control analysis

2018 ◽  
Vol 29 (2) ◽  
pp. 198-203 ◽  
Author(s):  
Benedict U Nwachukwu ◽  
Michael A Gaudiani ◽  
Nathan A Marsh ◽  
Anil S Ranawat

Purpose: The goal of this study was to: (1) investigate the association between labral hypertrophy and radiographic and computed tomography (CT) imaging measurements of dysplasia in a femoroacetabular impingement (FAI) cohort; (2) evaluate the association between physical examination parameters suggestive of microinstability and labral hypertrophy. Methods: A retrospective case-control study was performed. Labral hypertrophy was defined as intraoperative labral width measuring greater >4 mm. A control cohort (NL) was matched to the cases. Physical examination parameters and preoperative radiographic and CT imaging studies were reviewed. Results: 231 hip arthroscopies for FAI were reviewed from which 42 cases of labral hypertrophy were identified (LH). In the LH group there was significantly increased hip internal rotation at 90° hip flexion compared to normal controls (13.6° ± 1 0.7° LH vs. 9.3° ± 6.2° NL; p = 0.04). On plain radiographs, the mean lateral centre-edge angle was smaller in the LH group compared to the NL group (27.6° ± 6.00° LH vs. 31.6° ± 6.59° NL; p < 0.001) and the acetabular index was larger in the LH group compared to the NL group (6.61 ± 4.18 LH vs. 4.14 ± 6.13 NL; p = 0.04). On CT imaging coronal sagittal CEA was significantly lower in LH cases compared to NL control (31.8° ± 5.30° LH vs. 35.1° ± 7.67° NL; p = 0.01). Conclusions: We found that patients with labral hypertrophy have radiographic and CT measurements consistent with subtle but not absolute dysplasia and physical examination findings suggestive of microinstability. We propose that labral hypertrophy can be a useful clinical tool for identifying FAI patients on the dysplasia spectrum.

2009 ◽  
Vol 2009 ◽  
pp. 1-5 ◽  
Author(s):  
Florence Trivin ◽  
Eveline Boucher ◽  
Elodie Vauléon ◽  
Isabelle Cumin ◽  
Elisabeth Le Prisé ◽  
...  

Objectives. Esophageal carcinoma and cirrhosis have the overlapping etiologic factors.Methods. In a retrospective analysis conducted in 2 Breton institutions we wanted to asses the frequency of this association and the outcome of these patients in a case-control study where each case (cirrhosis and esophageal cancer) was paired with two controls (esophageal cancer).Results. In a 10-year period, we have treated 958 esophageal cancer patients; 26 (2.7%) had a cirrhosis. The same treatments were proposed to the 2 groups; cases received nonsignificantly different radiation and chemotherapy dose than controls. Severe toxicities and deaths were more frequent among the cases. At the end of the treatment 58% of the cases and 67% of the controls were in complete remission; median and 2-year survival were not different between the 2 groups. All 4 Child-Pugh B class patients experienced severe side effects and 2 died during the treatment.Conclusions. This association is surprisingly infrequent in our population! Child-Pugh B patients had a dismal prognosis and a bad tolerance to radiochemotherapy; Child-Pugh A patients have the same tolerance and the same prognosis as controls and the evidence of a well-compensated cirrhosis has not modified our medical options.


Author(s):  
Dr. Laurel Henderson ◽  
Mrs. Amna Imran ◽  
Ms. Pardis Barati Mahvar ◽  
Mr. Andrew Sanapanya ◽  
Dr. Parish P. Sedghizadeh

Sign in / Sign up

Export Citation Format

Share Document